Condensed Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Gain (Loss)	Accumulated Deficit
Balance at Dec. 31, 2022	$ 108,539	$ 3	$ 240,107	$ (1)	$ (131,570)
Balance (in shares) at Dec. 31, 2022		29,561,554
Exercise of stock options	407		407
Exercise of stock options, (in shares)		44,501
Issuance of restricted stock (in shares)		45,079
Stock-based compensation expense	3,233		3,233
Unrealized gain (loss) on investments, net	1			$ 1
Net loss	(29,051)				(29,051)
Balance at Mar. 31, 2023	83,129	$ 3	243,747		(160,621)
Balance (in shares) at Mar. 31, 2023		29,651,134
Balance at Dec. 31, 2023	169,237	$ 4	418,058		(248,825)
Balance (in shares) at Dec. 31, 2023		35,866,610
Exercise of stock options	$ 116		116
Exercise of stock options, (in shares)	22,750	22,750
Issuance of restricted stock (in shares)		44,226
Stock-based compensation expense	$ 5,022		5,022
Net loss	(39,061)				(39,061)
Balance at Mar. 31, 2024	$ 135,314	$ 4	$ 423,196		$ (287,886)
Balance (in shares) at Mar. 31, 2024		35,933,586